Subscribe to Newsletter


Reset Filter
You have a filtered search result

252 search results for ‘*’

Manufacture Bioprocessing - Upstream & Downstream

Frozen Assets

| Brian Moloney | 3 min read

Cryogenic freezing performed too fast can damage biopharma products. What’s the best way forward? An expert gives their view.

Discovery & Development Formulation

MR Control

| Asma Patel, John McDermott | 4 min read

Developing modified release formulations can be complex – but a translational pharmaceutics approach can smooth the path

Manufacture Advanced Medicine

Enter Exon Editing

| Michael Ehlers | 4 min read

If we can edit RNA at the kilobase scale, we can treat more diseases at the genetic level

Business & Regulation Supply Chain

The Intersection of Sustainability

| Sreedhar Patnala | 3 min read

How pharmaceutical companies are aligning their sustainability goals with the complexities of the modern supply chain

Discovery & Development Drug Discovery

Top Treatment Prospects: Alzheimer’s Disease

| Jamie Irvine | 9 min read

Experts discuss the most exciting Alzheimer’s Disease treatment trends – and make bold predictions for the future

Manufacture Advanced Medicine

Advanced Therapies, Archaic Hardware: the Perils of Paper

| Matt Todd | 4 min read

Here’s how paper is weighing down the future of advanced therapies.

Discovery & Development Drug Discovery

Advancements in the Fight Against Alzheimer's Disease

| Mallikarjun Chityala | 3 min read

Progress in Alzheimer’s Disease research, but a cure will take time. Delaying it and disseminating that research may buy scientists the time they need

Discovery & Development Drug Discovery

Treating the Fentanyl Epidemic

| Andrew Barrett | 4 min read

How – and why – we are tackling opioid use disorder with a monoclonal antibody

Manufacture Bioprocessing - Upstream & Downstream

Pushing the Boundaries of Bioprocessing

| Jungmin Oh | 4 min read

Biopharma tech continues to advance so why is downstream processing such a headache?

Business & Regulation Standards & Regulation

Saying Farewell to the Famous Horse Tweet

| Stephanie Vine | 5 min read

Why the FDA must delete its statement that people are not horses (or cows), referring to ivermectin use

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine